CompletedNot Applicable

Transversus Abdominis and Transversalis Fascia Plane Block Combination for Cesarean Section

Turkey (Türkiye)100 participantsStarted 2024-01-01

Plain-language summary

Cesarean delivery rates are rising globally, and effective postoperative analgesia is crucial for maternal recovery and newborn care. While intrathecal morphine offers strong analgesia, it may cause side effects such as nausea, pruritus, or respiratory depression. The transversus abdominis plane (TAP) block provides somatic pain relief but is often insufficient alone. The transversalis fascia plane block (TFPB) has been shown to enhance lower abdominal analgesia. This study aims to evaluate whether combining TAP and TFP blocks can provide analgesic efficacy comparable to intrathecal morphine in cesarean section patients who are unable to receive opioids or are at high risk of side effects.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-45 years old * American Society of Anesthesiologists physical score I or II * caesarean section with a Pfannenstiel incision Exclusion Criteria: * additional surgical intervention, or received general anaesthesia, * hypersensitivity to the agents to be used * BMI greater than 35 kg m-2 * coagulopathy, * local infection, * opioid addiction, * pregnancy-related hypertension * diabetes mellitus

What they're measuring

The Obstetric Quality of Recovery-10 (ObsQoR-10) Score

Timeframe: Postoperative 24 hours

Trial details

NCT IDNCT06944912

SponsorAtaturk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Ceserean Section and Postoperative Pain trials